Report of the directors financial review risk report (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Report Of The Directors Financial Review Risk Report [Abstract] |
|
| Disclosure of credit risk |
| | | | | | | | | | | | | | | | Summary of credit risk (excluding debt instruments measured at FVOCI) by stage distribution and ECL coverage by industry sector | | Gross carrying/nominal amount1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | – non-bank financial institutions | | | | | | | | | | | | | | | | Loans and advances to banks at amortised cost | | | | | | | | | | | | | | | | Other financial assets measured at amortised cost | | | | | | | | | | | | | | | | Loan and other credit-related commitments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | – non-bank financial institutions | | | | | | | | | | | | | | | | Loans and advances to banks at amortised cost | | | | | | | | | | | | | | | | Other financial assets measured at amortised cost | | | | | | | | | | | | | | | | Loan and other credit-related commitments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Represents the maximum amount at risk should the contracts be fully drawn upon and clients default. 2Purchased or originated credit-impaired (‘POCI‘). | | | | | | | | | | | | | Stage 2 days past due analysis | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | – non-bank financial institutions | | | | | | | | | | | | | Loans and advances to banks at amortised cost | | | | | | | | | | | | | Other financial assets measured at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | – corporate and commercial | | | | | | | | | | | | | – non-bank financial institutions | | | | | | | | | | | | | Loans and advances to banks at amortised cost | | | | | | | | | | | | | Other financial assets measured at amortised cost | | | | | | | | | | | | |
1The DPD amounts are presented on a contractual basis.
|
| Disclosure of macroeconomic variables and probabilities |
The following table describes key macroeconomic variables in the consensus Central scenario. | | | | | | | | | | | | | | | Consensus Central scenario | | | | | | | | | | | | | | | | | | | | | | | | | | GDP (annual average growth rate, %) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | House prices (annual average growth rate, %) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Inflation (annual average growth rate, %) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Central bank policy rate (annual average, %)2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1The five-year average is calculated over the 20 quarter projection. For the 2Q26 scenario this is from 3Q26 to 2Q31. For the 4Q25 scenario it is from 1Q26 to 4Q30. 2For the Chinese mainland, rate shown is the Loan Prime Rate. | | | | | | | | | | | | | | | Consensus Upside scenario (3Q26–2Q31) | | | | | | | | | GDP level (%, start-to-peak)1 | | | | | | | | | | | | | | | Unemployment rate (%, min)2 | | | | | | | | | | | | | | | House price index (%, start-to-peak)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, min)3 | | | | | | | | | | | | | | | Central bank policy rate (%, min)3 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Consensus Upside scenario 2026–2030 (as at 4Q25) | | | | | | | | | GDP level (%, start-to-peak)1 | | | | | | | | | | | | | | | Unemployment rate (%, min)2 | | | | | | | | | | | | | | | House price index (%, start-to-peak)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, max)3 | | | | | | | | | | | | | | | Central bank policy rate (%, max)3 | | | | | | | | | | | | | | |
1Cumulative change to the highest level of the series during the 20-quarter projection. 2Lowest projected unemployment rate in the scenario. 3Lowest/highest projected policy rate and year-on-year percentage change in inflation in the scenario. For the Chinese mainland, the policy rate shown is the Loan Prime Rate. The following table describes key macroeconomic variables in the consensus Downside scenario. | | | | | | | | | | | | | | | Consensus Downside scenario (3Q26–2Q31) | | | | | | | | | GDP level (%, start-to-trough)1 | | | | | | | | | | | | | | | Unemployment rate (%, max)2 | | | | | | | | | | | | | | | House price index (%, start-to-trough)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, max)3 | | | | | | | | | | | | | | | Central bank policy rate (%, max)3 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Consensus Downside scenario 2026–2030 (as at 4Q25) | | | | | | | | | GDP level (%, start-to-trough)1 | | | | | | | | | | | | | | | Unemployment rate (%, max)2 | | | | | | | | | | | | | | | House price index (%, start-to-trough)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, min)3 | | | | | | | | | | | | | | | Central bank policy rate (%, min)3 | | | | | | | | | | | | | | |
1Cumulative change to the lowest level of the series during the 20-quarter projection. 2The highest projected unemployment rate in the scenario. 3Lowest/highest projected policy rate and year-on-year percentage change in inflation in the scenario. For the Chinese mainland, the policy rate shown is the Loan Prime Rate. | | | | | | | | | | | | | | | Downside 2 scenario (3Q26–2Q31) | | | | | | | | | GDP level (%, start-to-trough)1 | | | | | | | | | | | | | | | Unemployment rate (%, max)2 | | | | | | | | | | | | | | | House price index (%, start-to-trough)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, max)3 | | | | | | | | | | | | | | | Central bank policy rate (%, max)3 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Downside 2 scenario 2026–2030 (as at 4Q25) | | | | | | | | | GDP level (%, start-to-trough)1 | | | | | | | | | | | | | | | Unemployment rate (%, max)2 | | | | | | | | | | | | | | | House price index (%, start-to-trough)1 | | | | | | | | | | | | | | | Inflation rate (YoY % change, min)3 | | | | | | | | | | | | | | | Central bank policy rate (%, min)3 | | | | | | | | | | | | | | |
1Cumulative change to the lowest level of the series during the 20-quarter projection. 2The highest projected unemployment rate in the scenario. 3 Lowest/highest projected policy rate and year-on-year percentage change in inflation in the scenario. For the Chinese mainland, the policy rate shown is the Loan Prime Rate. | | | | | | | Wholesale IFRS 9 ECL sensitivity to future economic conditions1,2,3 | By geography at 30 Jun 20265 | Reported Gross carrying amount4 | Reported allowance for ECL | Consensus Central scenario allowance for ECL | Consensus Upside scenario allowance for ECL | Consensus Downside scenario allowance for ECL | Downside 2 scenario allowance for ECL | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | By geography at 31 Dec 20255 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Allowance for ECL sensitivity includes off-balance sheet financial instruments. These are subject to significant measurement uncertainty. 2Includes low credit-risk financial instruments such as debt instruments at FVOCI, which have high carrying amounts but low ECL under all the above scenarios. 3Excludes defaulted obligors. For a detailed breakdown of performing and non-performing wholesale portfolio exposures, see page 63. 4Staging refers only to probability-weighted/reported gross carrying amount. Stage allocation of gross exposures varies by scenario, with higher allocation to stage 2 under the Downside 2 scenario. 5Geographies include all legal entities which share a common set of macroeconomic scenarios for the majority of exposures. 6Includes small portfolios that use less complex modelling approaches and are not sensitive to macroeconomic changes. | | | | | | | | | | | | | Retail IFRS 9 ECL sensitivity to future economic conditions1 | | | | | | | | | | | Reported gross carrying amount | Reported allowance for ECL | Consensus Central scenario allowance for ECL | Consensus Upside scenario allowance for ECL | Consensus Downside scenario allowance for ECL | Downside 2 scenario allowance for ECL | Reported gross carrying amount | Reported allowance for ECL | Consensus Central scenario allowance for ECL | Consensus Upside scenario allowance for ECL | Consensus Downside scenario allowance for ECL | Downside 2 scenario allowance for ECL | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Allowance for ECL sensitivities includes defaulted obligors and excludes portfolios utilising less complex modelling approaches. Downside scenario or the Downside 2 scenario at 30 June 2026, it would increase/(decrease) as presented in the below table. | | | | | | Total Group ECL at 30 Jun 2026 | | | | | | | | | 100% consensus Central scenario | | | 100% consensus Upside scenario | | | 100% consensus Downside scenario | | | | | |
| | | Total Group ECL at 31 Dec 2025 | | | | | | | | | 100% consensus Central scenario | | | 100% consensus Upside scenario | | | 100% consensus Downside scenario | | | | | |
1On the same basis as retail and wholesale sensitivity analysis.
|
| Disclosure of reconciliation of changes in loss allowance |
| | | | | | | Management judgemental adjustments to ECL1 | | | | | | | | | | | | | | | | | | | | | | | | | Banks, sovereigns, government entities and low-risk counterparties | | | | | | | Corporate lending adjustments | | | | | | | | | | | | | | Total management judgemental adjustments (B)4 | | | | | | | | | | | | | | | | | | | | |
1Management judgemental adjustments presented in the table reflect increases or (decreases) in allowance for ECL, respectively. 2The wholesale portfolio corresponds to adjustments to the performing portfolio (stage 1 and stage 2). 3(A) refers to probability-weighted allowance for ECL before any adjustments are applied. 4(B) refers to adjustments that are applied where management believes allowance for ECL does not sufficiently reflect the credit risk/expected credit losses of any given portfolio at the reporting date. These can relate to risks or uncertainties that are not reflected in the model, and/or to any late-breaking events. 5(C) refers to adjustments to allowance for ECL made to address process limitations, data/model deficiencies, and can also include, where appropriate, the impact of new models where governance has sufficiently progressed to allow an accurate estimate of ECL allowance to be incorporated into the total reported ECL. At 30 June 2026 a qualitative industry sector framework adjustment increased the wholesale portfolio allowance for ECL by $0.1bn. 6As presented within our internal credit risk governance (see page 140 of the Annual Report and Accounts 2025 on Form 20-F). | | | | | | | | | | | Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan commitments and financial guarantees | | | | | | | | | | | | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | | | | | | | | | | | | | | | | | | | | | | | Transfers of financial instruments: | | | | | | | | | | | – transfers from stage 1 to stage 2 | | | | | | | | | | | – transfers from stage 2 to stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net remeasurement of ECL arising from transfer of stage | | | | | | | | | | | Changes due to modifications not derecognised | | | | | | | | | | | Net new and further lending/ repayments | | | | | | | | | | | Changes to risk parameters – credit quality | | | | | | | | | | | Changes to models used for ECL calculation | | | | | | | | | | | | | | | | | | | | | | Credit-related modifications that resulted in derecognition | | | | | | | | | | | Foreign exchange and others1 | | | | | | | | | | | | | | | | | | | | | | ECL income statement change for the period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total ECL income statement change for the period | | | | | | | | | | |
1Total includes $4.7bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, and a corresponding allowance for ECL of $52m, reflecting planned business disposals as disclosed in Note 15 on page 100. | | | | Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan commitments and financial guarantees (continued) | | | 6 months ended 30 Jun 2026 | Gross carrying/ nominal amount | | | | | | | | | | | Other financial assets measured at amortised cost | | | | Non-trading reverse purchase agreement commitments | | | | Performance and other guarantees not considered for IFRS 9 | | | | Summary of financial instruments to which the impairment requirements in IFRS 9 are applied – by business segment/Summary consolidated income statement | | | | Debt instruments measured at FVOCI | | | | Total allowance for ECL/total income statement ECL change for the period | | | |
| | | | | | | | | | | | | | | | | | | | | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | Gross carrying/ nominal amount | | | | | | | | | | | | | | | | | | | | | | | | Transfers of financial instruments: | | | | | | | | | | | – transfers from stage 1 to stage 2 | | | | | | | | | | | – transfers from stage 2 to stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net remeasurement of ECL arising from transfer of stage | | | | | | | | | | | Changes due to modifications not derecognised | | | | | | | | | | | Net new and further lending/repayments | | | | | | | | | | | Changes to risk parameters – credit quality | | | | | | | | | | | Changes to models used for ECL calculation | | | | | | | | | | | | | | | | | | | | | | Credit-related modifications that resulted in derecognition | | | | | | | | | | | Foreign exchange and others1,2 | | | | | | | | | | | | | | | | | | | | | | ECL income statement change for the period | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total ECL income statement change for the period2 | | | | | | | | | | |
1Total includes $6.0bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, and a corresponding allowance for ECL of $27m, including business disposals as disclosed in Note 23 ‘Assets held for sale and liabilities of disposal groups held for sale’ on page 355 of the Annual Report and Accounts 2025 on Form 20-F. 2This includes $7.2bn of gross carrying loans and advances to customers and corresponding allowance for ECL of $7m in relation to disposal of our retained portfolio of home and other retail loans in France, as disclosed in Note 23 on page 355 of the Annual Report and Accounts 2025 on Form 20-F. | | | | Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan commitments and financial guarantees (continued) | | | 12 months ended 31 Dec 2025 | Gross carrying/ nominal amount | | | | | | | | | | | Other financial assets measured at amortised cost | | | | Non-trading reverse purchase agreement commitments | | | | Performance and other guarantees not considered for IFRS 9 | | | | Summary of financial instruments to which the impairment requirements in IFRS 9 are applied – by business segment/Summary consolidated income statement | | | | Debt instruments measured at FVOCI | | | | Total allowance for ECL/total income statement ECL change for the period | | | |
| | | | | | | | | | | | | | | | | Distribution of financial instruments to which the impairment requirements in IFRS 9 are applied, by credit quality and stage allocation | | | | | Gross carrying/nominal amount | | | Gross carrying/nominal amount | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Other financial assets measured at amortised cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loan and other credit- related commitments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Debt instruments at FVOCI1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1For the purposes of this disclosure, gross carrying value is defined as the amortised cost of a financial asset, before adjusting for any loss allowance. As such, the gross carrying value of debt instruments at FVOCI will not reconcile to the balance sheet as it excludes fair value gains and losses.
|
| Disclosure of compliance with regulatory capital requirements under banking regulations |
| | | | | | | | | | | | | | Common equity tier 1 capital before regulatory adjustments | | | | Total regulatory adjustments to common equity tier 1 | | | | Common equity tier 1 capital | | | | Additional tier 1 capital before regulatory adjustments | | | | Total regulatory adjustments to additional tier 1 capital | | | | Additional tier 1 capital | | | | | | | | Tier 2 capital before regulatory adjustments | | | | Total regulatory adjustments to tier 2 capital | | | | | | | | | | | | | | | | Common equity tier 1 ratio | | | | | | | | | | |
*These are references to lines prescribed in the Pillar 3 ‘Own funds disclosure’ template.
|
| Disclosure of value at risk |
| | | | | Non-trading VaR, 99% 10 day | | | | Portfolio diversification1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Portfolio diversification is the market risk dispersion effect of holding a portfolio containing different risk types. It represents the reduction in unsystematic market risk that occurs when combining a number of different risk types – such as interest rate and credit spreads – together in one portfolio. It is measured as the difference between the sum of the VaR by individual risk type and the combined total VaR. A negative number represents the benefit of portfolio diversification. As the maximum and minimum occurs on different days for different risk types, it is not meaningful to calculate a portfolio diversification benefit for these measures. 2The total VaR is non-additive across risk types due to diversification effects. | | | | | | | | | Foreign exchange and commodity | | | | Portfolio diversification1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1See page 75 for our definition of portfolio diversification. 2The total VaR is non-additive across risk types due to diversification effects.
|
| Additional information about insurance contracts |
| | | | | | Balance sheet of insurance manufacturing subsidiaries by type of contract | | Life direct participating and investment DPF contracts | | | Shareholder assets and liabilities | | | | | | | | | | | | | | – financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | – financial investments – at amortised cost | | | | | | – financial assets at fair value through other comprehensive income | | | | | | | | | | | | Insurance contract assets | | | | | | Reinsurance contract assets | | | | | | | | | | | | Other assets and investment properties | | | | | | Total assets at 30 Jun 2026 | | | | | | Liabilities under investment contracts designated at fair value | | | | | | Insurance contract liabilities | | | | | | Reinsurance contract liabilities | | | | | | Liabilities of disposal groups held for sale1 | | | | | | | | | | | | | | | | | | | | | | | | Total liabilities and equity at 30 Jun 2026 | | | | | | | | | | | | | | | | | | – financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | – financial investments – at amortised cost | | | | | | – financial assets at fair value through other comprehensive income | | | | | | | | | | | | Insurance contract assets | | | | | | Reinsurance contract assets | | | | | | | | | | | | Other assets and investment properties | | | | | | Total assets at 31 Dec 2025 | | | | | | Liabilities under investment contracts designated at fair value | | | | | | Insurance contract liabilities | | | | | | Reinsurance contract liabilities | | | | | | Liabilities of disposal groups held for sale1 | | | | | | | | | | | | | | | | | | | | | | | | Total liabilities and equity at 31 Dec 2025 | | | | | |
1HSBC Life (Singapore) Pte. Ltd. and HSBC Life Assurance (Malta) Ltd. are classified as held for sale at 30 June 2026. HSBC Life (UK) Limited was classified as held for sale at 31 December 2025. ÑFurther details are provided on page 100.
|